Scientists create drug to replace antibiotics

07 November 2014

Staphefekt, developed by the Dutch biotechnology company Micreos, is the world's first bacteria-killing enzyme targeting the Staphylococcus aureus-bacteria. It is available in Gladskin creams and gels for people with skin problems. 

Read the full article on TheTimes.co.uk